search
Back to results

Image Guided Mapping for Cardiac Pacing Intervention (MAPIT-TOO)

Primary Purpose

Heart Failure

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Image guided Cardiac Resynchronization Therapy (CRT) device lead placement.
optimizing myocardial lead placement for Cardiac Resynchronization Therapy (CRT) devices
Sponsored by
Lawson Health Research Institute
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Failure

Eligibility Criteria

41 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • any patient (> or equal to 40 years old) referred for cardiac resynchronization therapy
  • New York Heart Association (NYHA) greater than or equal to 2
  • ejection fraction </=35%
  • QRS duration >/=120 msec
  • Patient has been on stable heart failure medications for at least 6 weeks and in the investigator's opinion reached optimal medical therapy for treatment of heart failure over the past 6 months

Exclusion Criteria:

  • patients with contraindications to MRI
  • recent myocardial infarction within last 6 weeks
  • cardiac revascularization procedure within the past 3 months
  • glomerular filtration rate (GFR) </= 30ml/min/m2
  • unable to give informed consent
  • pregnant women

Sites / Locations

  • London Health Sciences Centre

Outcomes

Primary Outcome Measures

improvement in LVESV by greater than/equal to 15%

Secondary Outcome Measures

improvement in ejection fraction greater than or equal to 5%,
improvement in 6 minute walk equal to or greater than 30 meters
improvement in NYHA functional class by 1
improved QoL by 10 points

Full Information

First Posted
June 29, 2011
Last Updated
November 2, 2017
Sponsor
Lawson Health Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT01638754
Brief Title
Image Guided Mapping for Cardiac Pacing Intervention
Acronym
MAPIT-TOO
Official Title
Multi-Modality Imaging Assessment for Pacing Interventions in Heart Failure: Targeting Optimal Sites and Outcomes
Study Type
Interventional

2. Study Status

Record Verification Date
November 2017
Overall Recruitment Status
Completed
Study Start Date
May 1, 2011 (Actual)
Primary Completion Date
August 2014 (Actual)
Study Completion Date
December 18, 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Lawson Health Research Institute

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Patients with heart failure and cardiomyopathy that have been referred for Cardiac Resynchronization Therapy (CRT) will have their CRT devices implanted using an image guided treatment plan for optimal lead delivery. The validation of image-guided CRT lead delivery will significantly advance the field of heart failure therapy.
Detailed Description
Objective 1: Using established study data from our previous study (Multimodality imaging Assessment of Pacing InTervention in Heart Failure Heart Failure or MAPIT HF) define characteristics of the "optimal myocardial target" that maximally yields clinical response to CRT. Objective 2: Using established MAPIT-HF study data identify whether alternate coronary venous pathways to "optimal myocardial targets" exists in clinical non-responders. Objective 3: Evaluate the feasibility of guiding the delivery of CRT leads to "optimal myocardial targets" through the use of an interactive, 3D "integrated cardiac model" of coronary vein anatomy, myocardial scar and mechanical dyssynchrony. Currently there is no standard definition for response to CRT. Of importance is that measures of clinical response appear to be incongruent with echocardiographic parameters of reverse remodeling following CRT. The primary endpoint of clinical response will be an improvement in Left ventricular end systolic volume (LVESV) by ≥ 15% at 3 months following CRT, as validated in prior studies. Secondary clinical endpoints will also be evaluated; 1) Improvement in ejection fraction ≥ 5 percentage points, 2) Improvement in 6-minute hall walk ≥ 30 meters or ≥ 10%, 3) Improvement in NYHA (New York Heart Association) functional class by 1, or Specific Activity Score by 1, and 4) Improvement in Quality of Life (Minnesota Living with Heart Failure) by 10 points. Our hypothesis is that a single 3D dataset can be developed from multiple MRI datasets for the simultaneous display of coronary venous anatomy, myocardial scar, and mechanical dyssynchrony, the latter being derived from tagged MRI data. The investigators hypothesize that the availability of this 3D model during fluoroscopic CRT lead placement will result in improved rates of lead tip delivery to "optimal myocardial targets" and improved clinical response. Our specific hypotheses of Project 2 are as follows; The generation of an integrated cardiac model of venous anatomy, myocardial scar and dyssynchrony is feasible using multiple MRI-derived datasets. The availability of this interactive 3D cardiac model during fluoroscopic CRT lead delivery will increase the occurrence of CRT lead tips being delivered to "optimal myocardial segments" when compared to historic control data within the MAPIT-HF study cohort.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
34 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
Image guided Cardiac Resynchronization Therapy (CRT) device lead placement.
Intervention Description
Participants will have a cardiac MRI scan prior to insertion of CRT device and an image guided map will be created to guide placement of Cardiac Resynchronization Therapy (CRT) pacing leads to the most optimal target on the patients heart.
Intervention Type
Procedure
Intervention Name(s)
optimizing myocardial lead placement for Cardiac Resynchronization Therapy (CRT) devices
Intervention Description
optimal lead placement will be determined by 3D model of coronary vein anatomy, myocardial scar and mechanical dyssynchrony
Primary Outcome Measure Information:
Title
improvement in LVESV by greater than/equal to 15%
Time Frame
3-6 months
Secondary Outcome Measure Information:
Title
improvement in ejection fraction greater than or equal to 5%,
Time Frame
3-6 months
Title
improvement in 6 minute walk equal to or greater than 30 meters
Time Frame
3-6 months
Title
improvement in NYHA functional class by 1
Time Frame
3-6 months
Title
improved QoL by 10 points
Time Frame
3-6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
41 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: any patient (> or equal to 40 years old) referred for cardiac resynchronization therapy New York Heart Association (NYHA) greater than or equal to 2 ejection fraction </=35% QRS duration >/=120 msec Patient has been on stable heart failure medications for at least 6 weeks and in the investigator's opinion reached optimal medical therapy for treatment of heart failure over the past 6 months Exclusion Criteria: patients with contraindications to MRI recent myocardial infarction within last 6 weeks cardiac revascularization procedure within the past 3 months glomerular filtration rate (GFR) </= 30ml/min/m2 unable to give informed consent pregnant women
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James White, MD, FRCPC
Organizational Affiliation
Lawson Health Research Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
London Health Sciences Centre
City
London
State/Province
Ontario
ZIP/Postal Code
N6A5A5
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Image Guided Mapping for Cardiac Pacing Intervention

We'll reach out to this number within 24 hrs